000 | 02843 a2200817 4500 | ||
---|---|---|---|
005 | 20250517064400.0 | ||
264 | 0 | _c20160524 | |
008 | 201605s 0 0 eng d | ||
022 | _a2041-1723 | ||
024 | 7 |
_a10.1038/ncomms9904 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWickström, Malin | |
245 | 0 | 0 |
_aWnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance. _h[electronic resource] |
260 |
_bNature communications _cNov 2015 |
||
300 |
_a8904 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 |
_aBenzeneacetamides _xpharmacology |
650 | 0 | 4 |
_aBrain Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aCamptothecin _xanalogs & derivatives |
650 | 0 | 4 |
_aCelecoxib _xpharmacology |
650 | 0 | 4 |
_aCisplatin _xpharmacology |
650 | 0 | 4 |
_aColorectal Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aDNA Modification Methylases _xgenetics |
650 | 0 | 4 |
_aDNA Repair Enzymes _xgenetics |
650 | 0 | 4 |
_aDacarbazine _xanalogs & derivatives |
650 | 0 | 4 |
_aDoxorubicin _xpharmacology |
650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xgenetics |
650 | 0 | 4 | _aFlow Cytometry |
650 | 0 | 4 | _aGene Expression Profiling |
650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
650 | 0 | 4 |
_aGlioma _xdrug therapy |
650 | 0 | 4 | _aGlucose-6-Phosphate Isomerase |
650 | 0 | 4 |
_aHeterocyclic Compounds, 3-Ring _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunoblotting |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 | _aIrinotecan |
650 | 0 | 4 |
_aMedulloblastoma _xdrug therapy |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aNeoplasm Transplantation |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 |
_aNeuroblastoma _xdrug therapy |
650 | 0 | 4 |
_aPyrans _xpharmacology |
650 | 0 | 4 |
_aPyrazines _xpharmacology |
650 | 0 | 4 |
_aPyridines _xpharmacology |
650 | 0 | 4 | _aReal-Time Polymerase Chain Reaction |
650 | 0 | 4 |
_aSulfones _xpharmacology |
650 | 0 | 4 | _aTemozolomide |
650 | 0 | 4 |
_aTriazoles _xpharmacology |
650 | 0 | 4 |
_aTumor Suppressor Proteins _xgenetics |
650 | 0 | 4 |
_aVincristine _xpharmacology |
650 | 0 | 4 |
_aWnt Proteins _xgenetics |
650 | 0 | 4 |
_aWnt Signaling Pathway _xdrug effects |
650 | 0 | 4 |
_abeta Catenin _xgenetics |
700 | 1 | _aDyberg, Cecilia | |
700 | 1 | _aMilosevic, Jelena | |
700 | 1 | _aEinvik, Christer | |
700 | 1 | _aCalero, Raul | |
700 | 1 | _aSveinbjörnsson, Baldur | |
700 | 1 | _aSandén, Emma | |
700 | 1 | _aDarabi, Anna | |
700 | 1 | _aSiesjö, Peter | |
700 | 1 | _aKool, Marcel | |
700 | 1 | _aKogner, Per | |
700 | 1 | _aBaryawno, Ninib | |
700 | 1 | _aJohnsen, John Inge | |
773 | 0 |
_tNature communications _gvol. 6 _gp. 8904 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/ncomms9904 _zAvailable from publisher's website |
999 |
_c25481813 _d25481813 |